ABOUT THE EVENT
Date: Wednesday, May 27, 2026 10–11am EDT
Event Location: Virtual
With antibodies serving as critical intermediates in ADCs, antibody development constitutes a major part of ADC projects. The ability to achieve efficient antibody development and robust large-scale production has become a key determinant in accelerating the overall ADC development timeline.
The session will discuss efficient upstream cell culture process development, robust scale-up, and process characterization in ADC programs, supported by practical case studies from AsymBio’s Upstream Process Development Platform. The presentation will illustrate how optimizing key process parameters can enhance intermediate quality and yield, supporting the transition from early-stage development through to commercial production.
Key Learning Objectives:
- Understand key considerations for efficient upstream cell culture process development
- Gain insight into scaling processes from laboratory to production scale
- Learn approaches for process characterization to ensure reproducibility and product quality
On-demand viewing will be available to all registered attendees after the live session.
